Literature DB >> 9305349

Mitochondrial trifunctional protein deficiency associated with recurrent myoglobinuria in adolescence.

H Miyajima1, K E Orii, Y Shindo, T Hashimoto, T Shinka, T Kuhara, I Matsumoto, H Shimizu, E Kaneko.   

Abstract

A 23-year-old man with recurrent myoglobinuria had low muscle-free carnitine levels and deficient fasting ketogenesis. Urinary organic acid analysis showed large amounts of C6-C14 3-hydroxydicarboxylic acids. Mitochondrial trifunctional protein (TP), harboring long-chain enoyl-coenzyme A (CoA) hydratase, long-chain 3-hydroxyacyl-CoA dehydrogenase, and long-chain 3-ketoacyl-CoA thiolase showed markedly decreased activity in fibroblasts. On immunoblot analysis, the TP content of his fibroblasts was less than 2% that of the control cells. TP deficiency can be a life-threatening disorder with early infantile onset, but it can also present in adolescence with recurrent myoglobinuria.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305349     DOI: 10.1212/wnl.49.3.833

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2 in total

1.  Performance of serum and dried blood spot acylcarnitine profiles for detection of fatty acid β-oxidation disorders in adult patients with rhabdomyolysis.

Authors:  Khalid Al-Thihli; Graham Sinclair; Sandra Sirrs; Michelle Mezei; Judie Nelson; Hilary Vallance
Journal:  J Inherit Metab Dis       Date:  2013-01-08       Impact factor: 4.982

2.  Genetic, biochemical, and clinical spectrum of patients with mitochondrial trifunctional protein deficiency identified after the introduction of newborn screening in the Netherlands.

Authors:  Marit Schwantje; Sabine A Fuchs; Lonneke de Boer; Annet M Bosch; Inge Cuppen; Eugenie Dekkers; Terry G J Derks; Sacha Ferdinandusse; Lodewijk Ijlst; Riekelt H Houtkooper; Rose Maase; W Ludo van der Pol; Maaike C de Vries; Rendelien K Verschoof-Puite; Ronald J A Wanders; Monique Williams; Frits Wijburg; Gepke Visser
Journal:  J Inherit Metab Dis       Date:  2022-04-19       Impact factor: 4.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.